Stocksigma LogoStocksigma Logo

Sun Pharma Clarifies News Report on Assam Facility and Share Price Movement

Sun Pharmaceutical Industries clarified that news reports regarding halted eye-care drug production at its Assam facility stem from developments in Aug'26

Sun Pharma Clarifies News Report on Assam Facility and Share Price Movement

Sun Pharmaceutical Industries Ltd 路 Others (Uncategorized) 路 03 Nov 2026, 2:28 am

Sun Pharma Clarifies News Report on Assam Facility and Share Price Movement Sun Pharmaceutical Industries clarified that news reports regarding halted eye-care drug production at its Assam facility stem from developments in Aug'26 rather than any new event on 30th Oct'26. The company noted the matter did not warrant a Regulation 30 disclosure when assessed. Sun Pharma also stated it cannot attribute recent share price fluctuations to the report or any specific factor, noting Q2/H1 FY27 financial results were announced on 30th Oct'26, and confirmed no undisclosed material events exist.

Original exchange filing (PDF)

More announcements from Sun Pharmaceutical Industries Ltd

All Sun Pharmaceutical Industries Ltd announcements